From Our Partners
Wednesday, July 6, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

General Dynamics Awarded $42M Contract in Support of Biodefense Research

by Global Biodefense Staff
September 13, 2012

General Dynamics Information Technology, a business unit of General Dynamics, was last week awarded a $41.8 million task order by the U.S. Army Medical Research Materiel Command to provide support services for vaccine, drug and medical device development programs to the U.S. Army Medical Materiel Development Activity (USAMMDA).   

USAMMDA develops new drugs, vaccines and medical support devices that enhance readiness, ensure provisions of the highest quality medical care to the DoD and maximize the survival of medical casualties on the battlefield. The product managers at USAMMDA guide promising new concepts and technologies developed in the USAMRMC laboratories through advanced development and the regulatory process to obtain U.S. FDA certification. Upon FDA certification, USAMMDA works in conjunction with the U.S. Army Medical Materiel Agency to develop plans for fielding medical materiel.

General Dynamics will deliver a wide range of services in support of USAMMDA’s mission. The company has partnered with Tunnell Government Services Inc., a life sciences technical services consulting leader in biotechnology, medical devices and pharmaceutical product development, on this contract. General Dynamics anticipates hiring more than 30 new employees to perform this work at Fort Detrick in Frederick, Md.

From Our Partners
Tags: Awards

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC